Clinical Trial Update: Selection of Resistant Mutations to Dolutegravir in PLWH Treated in Mozambique

View source ↗

Summary

This Mozambican clinical trial is studying the development of resistance mutations to dolutegravir in people living with HIV on ART. It is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Tivicay (dolutegravir)

Snippet

Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | Conditions: HIV, HIV Antiretroviral Therapy (ART) Adherence | Status: RECRUITING